A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment	IDH1-Mutated Malignancies	Recruiting	Phase 1	2026-08-06		NCT07006688

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut de Recherches Internationales Servier	18
Servier Bio-Innovation LLC	6

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	19
Emory University	Atlanta	United States	262
Fakultni nemocnice Ostrava	Ostrava	Czechia	1
Fakultni nemocnice v Motole FN Motol	Prague	Czechia	1
Hospital de Base de Sao Jose do Rio Preto	São José do Rio Preto	Brazil	17
Hospital Universitari Vall d'Hebron	Barcelona	Spain	22
Hospital Universitario 12 de Octubre	Madrid	Spain	2
ICON Cancer Centre	South Brisbane	Australia	5
Instituto do Cancer do Estado de Sao Paulo	São Paulo	Brazil	2
MD Anderson	Houston	United States	56
Royal Adelaide Hospital	Adelaide	Australia	132
Seoul National University Bundang Hospital	Seongnam-si	South Korea	107
Seoul National University Hospital	Seoul	South Korea	40
Severence Hospital, Yonsei University Health Systems	Seoul	South Korea	1
START - Hospital HM Nou Delfos	Barcelona	Spain	1
START Madrid - Fundacion Jimenez Diaz	Madrid	Spain	1
START Madrid Centro Oncologico Clara Campal Sanchinarro Univesrity Hospital	Madrid	Spain	1
The Ohio State University Wexner Medical Center, The James Cancer Hospital & Solove Research Institute	Columbus	United States	1
University Hospital Brno	Brno	Czechia	10
Vseobecna Fakultni Nemocnice V Praze	Prague	Czechia	6

Clinical trials